Genetic Technologies Ltd
GTG•Health Care•Biotechnology•Last updated: Dec 25
About
Genetic Technologies Ltd is a molecular diagnostics company specializing in the development and commercialization of genetic risk assessment tests. The Company operates primarily in the field of predictive testing and assessment tools for cancer and other chronic diseases. Its key products include GeneType for Breast Cancer and GeneType for Colorectal Cancer, which are designed to provide personalized risk assessments based on genetic and clinical information.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- GTG
Related Shares
Investor Resources
Should you buy Genetic Technologies Ltd right now?
While GTG looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now